Evidence map›Paper›PMID 35299679›Full record

ArticleJournal of healthcare engineering2022

Association of Paraoxonase 1 Gene Polymorphisms with the Risk of Breast Fibroadenoma and Breast Cancer in the Females of Guangxi, China.

Kun Chen, Xiaogang Wang, Dihang Li, Weiping Luo, Chuang Xue, Yong Kong

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kun ChenDepartment of Thyroid Gland and Breast Surgery, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Wuzhou 543001, Guangxi, China.ORCID 0000-0001-5919-8769
Xiaogang WangDepartment of Medical Management, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Wuzhou 543001, Guangxi, China.
Dihang LiDepartment of Thyroid Gland and Breast Surgery, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Wuzhou 543001, Guangxi, China.
Weiping LuoDepartment of Thyroid Gland and Breast Surgery, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Wuzhou 543001, Guangxi, China.
Chuang XueDepartment of Thyroid Gland and Breast Surgery, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Wuzhou 543001, Guangxi, China.
Yong KongDepartment of Thyroid Gland and Breast Surgery, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Wuzhou 543001, Guangxi, China.
The People's Hospital of Guangxi Zhuang Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroadenoma of the breast is a common cause of a benign breast lump in premenopausal women. The consensus view is that women with fibroadenomas are not at significantly increased risk of developing breast cancer. The objective of this research was to explore the association of PON1 rs662 and rs705382 with the risk of breast fibroadenoma (BF) and breast cancer (BC) in the females of Guangxi in southern China. The PON1 rs662 and rs705382 single-nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 55 BF patients, 80 BC patients, and 98 healthy controls. Significant associations with FB and BC risks were observed for the rs662 SNP. Diagnosis is based on the combination of clinical examination, imaging, and nonsurgical tissue biopsy (the triple test) [21]. In haplotype analyses, the haplotype GA increases the risk and haploid GG decreases the risk in BF and BC. Our research indicated that the PON1 rs662 SNP might be a risk factor for BF and BC. The results of this research indicated that the locus of rs662 in PON1 is relevant to risk of developing BF and BC in the females of Guangxi. Further prospective studies are needed to support our conclusions.

Indexed as

Breast NeoplasmsFibroadenomaAryldialkylphosphataseCase-Control StudiesChinaFemaleGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideAryldialkylphosphatasePON1 protein, human

Identifiers

PMID35299679
PMCPMC8923756
OpenAlexW4220746911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.